Position in LLY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$34,803,863
+$6,492,423 QoQ
Shares Held
29,017
-5.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
3.17%
of 13F equity value
Holder Rank
#655
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JACOBS & CO/CA holds $94,475,102 across 9 Drug Manufacturers - General names. LLY ranks #1 (36.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
29,017 | $34,803,863 | |
| 2 | ABBV |
AbbVie Inc.
|
61,621 | $15,506,308 | |
| 3 | AMGN |
Amgen Inc
|
42,343 | $15,333,247 | |
| 4 | MRK |
Merck & Co., Inc.
|
103,952 | $13,357,832 | |
| 5 | JNJ |
Johnson & Johnson
|
48,675 | $12,361,989 | |
| 6 | PFE |
Pfizer Inc
|
82,804 | $1,993,920 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,090 | $516,730 | |
| 8 | NVS |
Novartis AG
|
2,520 | $394,934 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,803,863 | 29,017 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $28,311,440 | 30,781 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $32,929,272 | 30,641 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $23,927,680 | 31,360 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $23,857,515 | 30,605 | Shares | Sole | 2025-07-02 | |
| 2025-03-31 | $24,622,028 | 29,812 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | $22,689,852 | 29,391 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $19,264,765 | 21,745 | Shares | Sole | 2024-10-01 | |
| 2024-06-30 | $19,896,630 | 21,976 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $17,527,438 | 22,530 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $13,633,332 | 23,388 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $13,240,791 | 24,651 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $11,987,128 | 25,560 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $9,421,384 | 27,434 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $9,930,360 | 27,144 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $8,861,083 | 27,404 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $9,067,740 | 27,967 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $8,111,716 | 28,326 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $7,958,174 | 28,811 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $6,831,224 | 29,566 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $6,878,025 | 29,967 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $5,814,772 | 31,125 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $5,354,085 | 31,711 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $4,573,225 | 30,896 | Shares | Sole | 2020-12-03 | |
| 2020-06-30 | $5,346,357 | 32,564 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $4,535,450 | 32,695 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||